Europe watchdog advises suspending 'risky' osteoporosis drug
A committee of Europe's medicines watchdog on Friday recommended suspending the use of an osteoporosis drug, saying the risks, including heart attacks, outweighed the benefits.
Jan 10, 2014
0
0